US PHARMACOPEIA

Lobbying client · Maryland · filed 2026 to 2026

Pharmaceutical manufacturing

$40,000 Reported spend

3 Filings counted

1 Firms hired

1 Bills named

Spend is reported income plus in-house expenses across 3 filings. Everything on this page is grouped by the client's LDA id (72654), not by name.

Firms hired 1

KYLE HOUSE GROUP $40,000 3 filings

Bills named in these filings 1

HR 8595
Making appropriations for national security, Department of State, and related programs for the fiscal year en…

1 filing

Reported by year 1 year

2026 $40,000 3 filings

Issues lobbied 2

Foreign Relations 3
Health Issues 3

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

Agencies and chambers lobbied 3

HOUSE OF REPRESENTATIVES 2
SENATE 2
State, Dept of (DOS) 2

Recent filings 3 total

Q2

KYLE HOUSE GROUP

2nd Quarter (Apr 1 - June 30) 2026 · House · Senate · $20,000 income · posted Jul 20, 2026

View → Q1

KYLE HOUSE GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · House · Senate · $20,000 income · posted Apr 20, 2026

View → RR

KYLE HOUSE GROUP

1st Quarter (Jan 1 - Mar 31) 2026 · posted Apr 20, 2026

View →

Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.